Re: The Added Value of Percentage of Free to Total Prostate-Specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men Editorial Comment

Taneja Samir S.

首页> 外文期刊>The Journal of Urology >Re: The Added Value of Percentage of Free to Total Prostate-Specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men Editorial Comment

【24h】

Re: The Added Value of Percentage of Free to Total Prostate-Specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men Editorial Comment

机译：回复：免费总前列腺特异性抗原，PCA3和激肽释放酶面板相对于ERSPC风险计算器的前列腺癌百分比的附加值编辑评论

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Journal of Urology》 |2015年第1期|共1页
作者
Taneja Samir S.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
专利

1. Re: The Added Value of Percentage of Free to Total Prostate-Specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men Editorial Comment [J] . Taneja Samir S. The Journal of Urology . 2015,第1期

机译：Re：将额外的前列腺特异性抗原，PCA3和Kallikrein面板的额外值增加到预先打击男性中前列腺癌的ERSPC风险计算器编辑评论
2. Re: The Added Value of Percentage of Free to Total Prostate-Specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men Editorial Comment [J] . Taneja Samir S. The Journal of Urology . 2015,第1期

机译：回复：免费总前列腺特异性抗原，PCA3和激肽释放酶面板相对于ERSPC风险计算器的前列腺癌百分比的附加值编辑评论
3. The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the erspc risk calculator for prostate cancer in prescreened men [J] . VedderM.M., DeBekker-GrobE.W., LiljaH.G., European urology . 2014,第6期

机译：预先筛查的男性前列腺癌的erspc风险计算器中游离总前列腺特异性抗原，PCA3和激肽释放酶面板的百分比相对于前列腺癌的附加价值
4. Biochip-based Test-system for Cancer Diagnostics. Simultaneous Quantitation of Total and Free Forms of Prostate-specific Antigen [C] . T. Osipova, Z.Sokolova, T. Ryabykh, NSTI BioNano Conference and Trade Show . 2008

机译：基于Biochip的癌症诊断测试系统。同时定量总前列腺特异性抗原的自由形式
5. Studies on human prostate-specific antigen as a tumor antigen for the immunotherapy of prostate cancer in a mouse model. [D] . Willis, Richard Allen. 2002

机译：人类前列腺特异性抗原作为一种肿瘤抗原的免疫模型在小鼠模型中的研究。
6. The Added Value of Percentage of Free to Total Prostate-specific Antigen PCA3 and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men [O] . Moniek M. Vedder, Esther W. de Bekker-Grob, Hans G. Lilja, -1

机译：ERSPC危险计算器中前列腺癌总抗原中游离前列腺素原抗原总量PCA3游离蛋白和激肽释放酶面板所占百分比的附加值
7. The added value of percentage of free to total prostate-specific antigen, PCA3, and a kallikrein panel to the erspc risk calculator for prostate cancer in prescreened men [O] . Vedder, M.M. (Moniek), Bekker-Grob, E.W. (Esther) de, Lilja, H. (Hans), 2014

机译：预先筛查的男性前列腺癌的erspc风险计算器中，游离总前列腺特异性抗原，PCA3和激肽释放酶组的百分比相对于前列腺癌的附加价值

Re: The Added Value of Percentage of Free to Total Prostate-Specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men Editorial Comment

著录项

相似文献

相关主题

期刊订阅